Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
Add more filters










Publication year range
1.
Diabetes Obes Metab ; 11(7): 688-99, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19527482

ABSTRACT

AIM: 11 beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is considered to contribute to the aetiology of the metabolic syndrome, and specific inhibitors have begun to emerge as treatments for insulin resistance and other facets of the syndrome, including atherosclerosis. Given the role of glucocorticoids and 11beta-HSD1 in the anti-inflammatory response and the involvement of inflammation in the development of atherosclerosis, 11beta-HSD1 inhibition may exacerbate atherosclerosis. Our aim was to investigate in vivo the effects of a specific 11beta-HSD1 inhibitor (2922) on atherosclerosis while assessing glucose homeostasis. METHODS: We conducted a 12-week study administering 2922 (at three doses, 3, 10 and 100 mg/kg body weight) in Ldlr 3KO (Ldlr(-/-)Apob(100/100)Lep(ob/ob)) mice, a genetic model of obesity, insulin resistance, dyslipidaemia and atherosclerosis. Rosiglitazone and simvastatin were used to test the responsiveness of our model in both types of therapy. RESULTS: 2922 was effective in reducing 11beta-HSD1 activity in inguinal adipose tissue (>90% for 100 mg/kg) and was efficacious in improving glucose homeostasis at doses > or =10 mg/kg. Plasma insulin, blood glucose, glucose tolerance and homeostatic model assessment indices were all improved in mice treated with 2922 (100 mg/kg) compared with control animals. Despite an improvement in these parameters, no differences were observed in body weight, adipose or lean tissue masses in the 2922-treated mice. Interestingly, circulating lipids, proinflammatory cytokines and atherosclerosis were unaltered in response to 2922, although a small reduction in LDL cholesterol was detected. CONCLUSIONS: Importantly, 11beta-HSD1 inhibition leads to improved glucose metabolism and does not result in a worsening of atherosclerotic lesion area, yet retained antidiabetic potential in the face of multiple severe metabolic aberrations. This study reinforces the potential use of 11beta-HSD1 inhibitors in patients with the metabolic syndrome without negatively impacting atherosclerosis.


Subject(s)
11-beta-Hydroxysteroid Dehydrogenase Type 1/antagonists & inhibitors , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Hypoglycemic Agents/therapeutic use , Metabolic Syndrome/drug therapy , Simvastatin/pharmacology , Adipose Tissue/drug effects , Animals , Atherosclerosis/complications , Atherosclerosis/drug therapy , Blood Glucose/analysis , Body Composition/drug effects , Body Weight/drug effects , Cholesterol/blood , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/drug therapy , Disease Models, Animal , Dyslipidemias/complications , Dyslipidemias/drug therapy , Insulin/blood , Male , Metabolic Syndrome/complications , Mice , Mice, Knockout , Rosiglitazone , Thiazolidinediones/therapeutic use , Triglycerides/blood
2.
Cell Prolif ; 35 Suppl 1: 78-85, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12139710

ABSTRACT

The epithelium of the oral cavity and small intestine of the gastrointestinal tract have a high rate of cell renewal and as such, are sensitive to cytotoxic therapies that kill rapidly dividing cells. Mucositis is a complication of cancer therapy where impairment of the regenerative capacity of the epithelium leads to atrophy, ulceration and a loss of barrier function. Keratinocyte growth factor (KGF) is an epithelial cell-specific growth and differentiation factor that is trophic for the mucosal epithelium of the gastrointestinal tract. In this study, KGF in normal animals caused epithelial thickening in the squamous epithelium of the oral cavity and increased crypt depth and villus height of the small intestine. It also appeared to regulate gene expression in these tissues including that of some antioxidant enzymes and intestinal trefoil protein. KGF has been shown to be efficacious in several preclinical models of mucositis where KGF pretreatment reduced weight loss typically seen during and after the course of therapy and significantly improved survival. At a tissue level KGF reduced atrophy, accelerated regrowth, and decreased ulcer formation of the oral epithelium after irradiation, and improved crypt survival and prevented villus atrophy in the small intestine of irradiated or chemotherapy-treated mice. Preliminary studies suggest that its efficacy may be partly a consequence of the growth and differentiation effect, and also partly due to regulation of the expression of genes that play a role in mucosal protection. These data suggest that KGF may be useful for the prevention or treatment of mucositis in patients treated with regimens of cancer therapy that have gastrointestinal toxicity.


Subject(s)
Fibroblast Growth Factors/pharmacology , Mouth Mucosa/pathology , Stomatitis/drug therapy , Stomatitis/pathology , Animals , Disease Models, Animal , Fibroblast Growth Factor 7 , Radiation Injuries, Experimental/drug therapy , Radiation Injuries, Experimental/pathology
3.
Br J Haematol ; 111(2): 501-12, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11122091

ABSTRACT

Osteoclast precursors (OCPs) circulate in the mononuclear fraction of peripheral blood (PB), but their abundance and surface characteristics are unknown. Previous studies suggest that the receptor activator for NF-kappaB (RANK) on cytokine-treated OCPs in mouse bone marrow interacts with osteoprotegerin ligand (OPGL/TRANCE/RANKL/ODF) to initiate osteoclast differentiation. Hence, we used a fluorescent form of human OPGL (Hu-OPGL-F) to identify possible RANK-expressing OCPs in untreated peripheral blood mononuclear cells (PBMCs) using fluorescence-activated cell sorting analysis. Monocytes [CD14-phycoerythrin (PE) antibody (Ab) positive (+) cells, 10-15% of PBMCs] all (98-100%) co-labelled with Hu-OPGL-F (n > 18). T lymphocytes (CD3-PE Ab+ cells, 66% of PBMCs) did not bind Hu-OPGL-F; however, B cells (CD19-PE Ab+ cells, 9% of PBMCs) were also positive for Hu-OPGL-F. All Hu-OPGL-F+ monocytes also co-labelled with CD33, CD61, CD11b, CD38, CD45 and CD54 Abs, but not CD34 or CD56 Abs. Hu-OPGL-F binding was dose dependent and competed with excess Hu-OPGL. When Hu-OPGL-F+, CD14-PE Ab+, CD33-PE Ab+, Hu-OPGL-F+/CD14-PE Ab+ or Hu-OPGL-F+/CD33-PE Ab+ cells were cultured with OPGL (20 ng/ml) and colony-stimulating factor (CSF)-1 (25 ng/ml), OC-like cells readily developed. Thus, all freshly isolated monocytes demonstrate displaceable Hu-OPGL-F binding, suggesting the presence of RANK on OCPs in PB; also, OCPs within a purified PB monocyte population form osteoclast-like cells in the complete absence of other cell types in OPGL and CSF-1 containing medium.


Subject(s)
Carrier Proteins , Glycoproteins/metabolism , Leukocytes, Mononuclear/metabolism , Membrane Glycoproteins , Osteoclasts/metabolism , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Tumor Necrosis Factor/metabolism , B-Lymphocytes/metabolism , Cell Differentiation , Cells, Cultured , Colony-Stimulating Factors/pharmacology , Dose-Response Relationship, Drug , Flow Cytometry , Glycoproteins/pharmacology , Humans , Leukocytes, Mononuclear/ultrastructure , Microscopy, Confocal , Microscopy, Electron, Scanning , Monocytes/metabolism , Osteoclasts/ultrastructure , Osteoprotegerin , Protein Binding , RANK Ligand , Receptor Activator of Nuclear Factor-kappa B
4.
J Biol Chem ; 274(14): 9843-6, 1999 Apr 02.
Article in English | MEDLINE | ID: mdl-10092675

ABSTRACT

Parkinson's disease (PD) is a neurodegenerative disorder that is pathologically characterized by the presence of intracytoplasmic Lewy bodies, the major component of which are filaments consisting of alpha-synuclein. Two recently identified point mutations in alpha-synuclein are the only known genetic causes of PD, but their pathogenic mechanism is not understood. Here we show that both wild type and mutant alpha-synuclein form insoluble fibrillar aggregates with antiparallel beta-sheet structure upon incubation at physiological temperature in vitro. Importantly, aggregate formation is accelerated by both PD-linked mutations. Under the experimental conditions, the lag time for the formation of precipitable aggregates is about 280 h for the wild type protein, 180 h for the A30P mutant, and only 100 h for the A53T mutant protein. These data suggest that the formation of alpha-synuclein aggregates could be a critical step in PD pathogenesis, which is accelerated by the PD-linked mutations.


Subject(s)
Mutation , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/genetics , Parkinson Disease/genetics , Phosphoproteins/chemistry , Phosphoproteins/genetics , Cell Line , Circular Dichroism , Cloning, Molecular , Humans , Protein Conformation , Protein Structure, Secondary , Spectroscopy, Fourier Transform Infrared , Synucleins , alpha-Synuclein
5.
J Immunol ; 162(5): 3022-30, 1999 Mar 01.
Article in English | MEDLINE | ID: mdl-10072554

ABSTRACT

Platelet/endothelial cell adhesion molecule-1 (PECAM-1; CD31), a member of the Ig superfamily, is expressed strongly at endothelial cell-cell junctions, on platelets, and on most leukocytes. CD31 has been postulated to play a role in vasculogenesis and angiogenesis, and has been implicated as a key mediator of the transendothelial migration of leukocytes. To further define the physiologic role of CD31, we used targeted gene disruption of the CD31 gene in embryonic stem cells to generate CD31-deficient mice. CD31-deficient mice (CD31KO) are viable and born at the expected Mendelian frequency, remain healthy, and exhibit no obvious vascular developmental defects. In response to inflammatory challenge, polymorphonuclear leukocytes of CD31KO mice are arrested between the vascular endothelium and the basement membrane of inflammatory site mesenteric microvessels, confirming a role for CD31 in the migration of neutrophils through the subendothelial extracellular matrix. Normal numbers of leukocytes are recovered from inflammatory sites in CD31KO mice, however, suggesting that the defect in leukocyte migration across basal lamina observed in the absence of CD31 may be compensated for by the use of other adhesion molecules, or possibly an increased rate of migration. Homing of T lymphocytes in vivo is normal, and CD31KO mice are able to mount a cutaneous hypersensitivity response normally. In addition, CD31-mediated homophilic adhesion does not appear to play a role in platelet aggregation in vitro. This study provides genetic evidence that CD31 is involved in transbasement membrane migration, but does not play an obligatory role in either vascular development or leukocyte migration.


Subject(s)
Platelet Endothelial Cell Adhesion Molecule-1/physiology , Animals , Blood Cell Count , Blood Platelets/physiology , Cell Movement , Female , Leukocytes/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , T-Lymphocytes/physiology
6.
Int J Radiat Biol ; 75(5): 609-20, 1999 May.
Article in English | MEDLINE | ID: mdl-10374943

ABSTRACT

PURPOSE: To investigate the effects of keratinocyte growth factor (KGF) on the structure of the stratified squamous epithelium of the tongue, buccal mucosa and oesophagus of normal and irradiated mice. MATERIALS AND METHODS: Female BDF1 mice were exposed to total body irradiation from a caesium source. The irradiated mice and normal, unirradiated mice were injected with 5 mg/kg per day KGF or vehicle. Thickness and proliferation in the epithelium were measured. RESULTS: KGF caused epithelial thickening of the non-keratinized layers in oral epithelium in normal mice. It increased the number of nucleated layers and influenced differentiation of post-mitotic cells in the upper layers by increasing the size and number of keratohyalin granules, and the number of desmosomes. Single and fractionated doses of radiation caused inhibition of proliferation as detected by markedly reduced BrdU incorporation following exposure, followed by epithelial atrophy. KGF treatment of mice reversed the inhibition of proliferation and atrophy that occurred in control irradiated mice. CONCLUSION: These data show that KGF reverses epithelial atrophy in mouse oral cavity caused by irradiation and suggest that KGF may be useful for the treatment of mucositis of the upper aerodigestive tract of patients treated with aggressive regimens of radiation therapy.


Subject(s)
Esophagus/radiation effects , Fibroblast Growth Factors , Growth Substances/pharmacology , Mouth Mucosa/radiation effects , Animals , Esophagus/drug effects , Esophagus/pathology , Female , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Growth Substances/genetics , Mice , Mice, Inbred BALB C , Mouth Mucosa/drug effects , Mouth Mucosa/pathology , RNA, Messenger/analysis , Whole-Body Irradiation
7.
Cell ; 94(3): 339-52, 1998 Aug 07.
Article in English | MEDLINE | ID: mdl-9708736

ABSTRACT

Mutation of Caspase 9 (Casp9) results in embryonic lethality and defective brain development associated with decreased apoptosis. Casp9-/- embryonic stem cells and embryonic fibroblasts are resistant to several apoptotic stimuli, including UV and gamma irradiation. Casp9-/- thymocytes are also resistant to dexamethasone- and gamma irradiation-induced apoptosis, but are surprisingly sensitive to apoptosis induced by UV irradiation or anti-CD95. Resistance to apoptosis is accompanied by retention of the mitochondrial membrane potential in mutant cells. In addition, cytochrome c is translocated to the cytosol of Casp9-/- ES cells upon UV stimulation, suggesting that Casp9 acts downstream of cytochrome c. Caspase processing is inhibited in Casp9-/- ES cells but not in thymocytes or splenocytes. Comparison of the requirement for Casp9 and Casp3 in different apoptotic settings indicates the existence of at least four different apoptotic pathways in mammalian cells.


Subject(s)
Apoptosis/genetics , Caspases , Cysteine Endopeptidases/physiology , Signal Transduction/genetics , Animals , Apoptosis/drug effects , Apoptosis/radiation effects , Caspase 9 , Cell Line , Cerebral Cortex/abnormalities , Cysteine Endopeptidases/genetics , Cytochrome c Group/metabolism , Dexamethasone/pharmacology , Embryo, Mammalian , Enzyme Activation/genetics , Fibroblasts/cytology , Fibroblasts/enzymology , Gamma Rays , Gene Expression Regulation, Developmental , Lymphocyte Activation , Membrane Potentials/genetics , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Knockout , Mitochondria/enzymology , Organ Specificity/genetics , Prosencephalon/abnormalities , Spleen/cytology , Spleen/immunology , Spleen/radiation effects , Stem Cells , Thymus Gland/cytology , Thymus Gland/enzymology
8.
Genes Dev ; 12(6): 806-19, 1998 Mar 15.
Article in English | MEDLINE | ID: mdl-9512515

ABSTRACT

Caspases are fundamental components of the mammalian apoptotic machinery, but the precise contribution of individual caspases is controversial. CPP32 (caspase 3) is a prototypical caspase that becomes activated during apoptosis. In this study, we took a comprehensive approach to examining the role of CPP32 in apoptosis using mice, embryonic stem (ES) cells, and mouse embryonic fibroblasts (MEFs) deficient for CPP32. CPP32(ex3-/-) mice have reduced viability and, consistent with an earlier report, display defective neuronal apoptosis and neurological defects. Inactivation of CPP32 dramatically reduces apoptosis in diverse settings, including activation-induced cell death (AICD) of peripheral T cells, as well as chemotherapy-induced apoptosis of oncogenically transformed CPP32(-/-) MEFs. As well, the requirement for CPP32 can be remarkably stimulus-dependent: In ES cells, CPP32 is necessary for efficient apoptosis following UV- but not gamma-irradiation. Conversely, the same stimulus can show a tissue-specific dependence on CPP32: Hence, TNFalpha treatment induces normal levels of apoptosis in CPP32 deficient thymocytes, but defective apoptosis in oncogenically transformed MEFs. Finally, in some settings, CPP32 is required for certain apoptotic events but not others: Select CPP32(ex3-/-) cell types undergoing cell death are incapable of chromatin condensation and DNA degradation, but display other hallmarks of apoptosis. Together, these results indicate that CPP32 is an essential component in apoptotic events that is remarkably system- and stimulus-dependent. Consequently, drugs that inhibit CPP32 may preferentially disrupt specific forms of cell death.


Subject(s)
Apoptosis/physiology , Caspases , Cell Nucleus/metabolism , Cysteine Endopeptidases/physiology , Animals , Apoptosis/drug effects , Apoptosis/genetics , B-Lymphocytes/cytology , B-Lymphocytes/physiology , Bone Marrow Cells/cytology , Bone Marrow Cells/physiology , CD3 Complex/pharmacology , Caspase 3 , Cell Death/physiology , Cell Division/physiology , Cysteine Endopeptidases/deficiency , Cysteine Endopeptidases/genetics , Cytotoxicity, Immunologic/genetics , Cytotoxicity, Immunologic/physiology , Embryo, Mammalian/cytology , Embryo, Mammalian/physiology , Embryonic and Fetal Development , Female , Gene Expression/genetics , Gene Expression/physiology , Longevity/genetics , Longevity/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Mutant Strains , Mutation/genetics , Mutation/physiology , Neutrophils/physiology , Osmotic Pressure , Stem Cells/radiation effects , T-Lymphocytes/cytology , T-Lymphocytes/drug effects , T-Lymphocytes/physiology , Tumor Cells, Cultured/cytology , Tumor Cells, Cultured/physiology , Tumor Cells, Cultured/radiation effects , Ultraviolet Rays , fas Receptor/pharmacology
9.
Biochim Biophys Acta ; 1281(2): 139-49, 1996 Jun 11.
Article in English | MEDLINE | ID: mdl-8664312

ABSTRACT

The present studies describe the biodistribution of cationic liposomes and cationic liposome/oligonucleotide complex following intravenous injection into mice via the tail vein. (111)In-diethylenetriaminepentaacetic acid stearylamide ((111)In-DTPA-SA) was used as a lipid-phase radiolabel. Inclusion of up to 5 mol% DTPA-SA in liposomes composed of 3beta-(N-(N',N'-dimethylaminoethane)carbamoyl)cholesterol (DC-Chol) and dioleoylphosphatidylethanolamine (DOPE) did not influence liposome formation or size, nor the binding/uptake or fusion of the cationic liposomes with CHO cells in vitro. Moreover, nuclear delivery of oligonucleotide to CHO cells was unaffected by the probe. The biodistribution of liposomes with increasing concentration of DC-Chol (1:4-4:1, DC-Chol/DOPE, mol/mol) at 24 h post-injection revealed no dependence on lipid composition. Uptake was primarily by liver, and accumulation in spleen and skin was also observed. Comparatively little accumulation occurred in lung. Clearance of injected liposomes by liver was very rapid (approximately 84.5% of the injected dose by 7.5 h post-injection). Liposome uptake by liver and spleen were equally efficient in the dose range of 3.33 to 33.33 mg/kg body weight, yet possible saturation of liver uptake at a dose of 66.80 mg/kg may have allowed for increased spleen accumulation. Preincubation of cationic liposomes with phosphorothioate oligonucleotide induced a dramatic yet transient accumulation of the lipid in lung which gradually redistributed to liver. Similar results were observed when monitoring iodinated oligonucleotide in the complex. Immuno-histochemical studies revealed large aggregates of oligonucleotide within pulmonary capillaries at 15 min post-injection, suggesting the early accumulation in lung was due to embolism. Immuno-histochemical studies further revealed labeled oligonucleotide to be localized primarily to Kupffer cells at 24 h post-injection. Immuno-electron microscopy revealed localization of oligonucleotide primarily to the lumen of pulmonary capillaries at 15 min post-injection. Immuno-electron microscopy revealed localization of oligonucleotide primarily to the lumen of pulmonary capillaries at 15 min post-injection, and to phagocytic vacuoles of Kupffer cells at 24 h post-injection. By these methods, nuclear delivery of oligonucleotide in vivo was not observed. Increasing concentration of mouse serum inhibited cellular binding/uptake of cationic liposomes in vitro, without or with complexed oligonucleotide. We therefore postulate that interaction with plasma components, including opsonin(s), inhibits cellular uptake of the injected liposomes as well as the liposome/oligonucleotide complex, and mediates rapid uptake by Kupffer cells of the liver. These results are relevant to the design of cationic liposomes for efficient delivery of nucleic acid in vivo.


Subject(s)
Liposomes/metabolism , Oligonucleotides/metabolism , Animals , Blood , Cations , Cholesterol/analogs & derivatives , Cholesterol/analysis , Immunohistochemistry , Indium Radioisotopes , Liposomes/chemistry , Liver/metabolism , Liver/ultrastructure , Lung/metabolism , Lysosomes/metabolism , Mice , Microscopy, Immunoelectron , Organ Specificity , Pentetic Acid/analogs & derivatives , Pentetic Acid/metabolism , Phosphatidylethanolamines/analysis , Skin/metabolism , Spleen/metabolism , Vacuoles/metabolism
10.
Am J Pathol ; 148(4): 1169-80, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8644858

ABSTRACT

Tubulointerstitial fibrosis correlates closely with renal function, although the mechanism regulating tubulointerstitial fibrogenesis remains poorly understood. Since platelet-derived growth factor (PDGF) is a growth factor for fibroblasts, we examined the effect of daily (for 7 days) PDGF-AA or PDGF-BB administration on renal tubulointerstitial architecture in rats. PDGF-AA administration at a dose of 5 mg/kg did not affect the renal tubulointerstitium. By comparison, PDGF-BB induced dose-dependent renal tubulointerstitial cell proliferation and fibrosis. At 5 mg/kg, PDGF-BB increased BrdU labeling in tubulointerstitial fibroblasts at 24 hours (19-fold), which peaked at 72 hours (23-fold) with bromodeoxyuridine uptake returning to control values by 7 days. Tubulointerstitial proliferation was associated with the differentiation of these cells into myofibroblasts as evidenced by alpha-smooth muscle actin expression beginning on day 3. The expression of alpha-smooth muscle actin peaked on day 5 and had markedly declined by day 21. In addition, apoptotic cells were identified within the tubulointerstitium on day 3 and progressively increased through day 7, suggesting that the disappearance of myofibroblasts may have occurred through apoptosis. These changes were accompanied by increased expression of alpha 1 (III) collagen mRNA and interstitial accumulation of type III collagen within the renal cortex. By morphometric analysis, an approximately twofold increase in collagen III immunolabeling within the interstitial compartment was evident at 24 hours and peaked on days 5 to 7 (approximately fourfold). These data suggest that PDGF-BB may be an important mediator of tubulointerstitial hyperplasia and fibrosis.


Subject(s)
Fibroblasts/pathology , Kidney Tubules/drug effects , Kidney Tubules/pathology , Nephritis, Interstitial/pathology , Platelet-Derived Growth Factor/adverse effects , Animals , Base Sequence , Cell Division/drug effects , Cells, Cultured , Collagen/drug effects , Collagen/metabolism , DNA/drug effects , Female , Fibroblasts/drug effects , Fibrosis , Kidney Tubules/ultrastructure , Molecular Sequence Data , Nephritis, Interstitial/chemically induced , Nephritis, Interstitial/metabolism , Rats , Rats, Inbred Lew
11.
Antisense Res Dev ; 5(3): 175-83, 1995.
Article in English | MEDLINE | ID: mdl-8785473

ABSTRACT

Oligonucleotides are a class of compounds with potential as therapeutics for a variety of clinical applications. Local delivery of oligonucleotides to the arterial wall is a challenging aspect of the development of these therapeutics for restenosis, and herein we report experiments characterizing the uptake and distribution of phosphorothiate oligonucleotides into vascular smooth muscle cells in primary cultures and in rabbit arteries. Primary cultures of smooth muscle cells incubated with rhodamine-oligonucleotides showed uptake only into cytoplasmic vesicles. No nuclear or cytosolic localization was detected. In normal arteries there was no visible tissue or cellular uptake of oligonucleotides after intralumenal administration. However, in balloon-injured arteries there was significant oligonucleotide uptake into the tissue with apparent cytoplasmic delivery to the medial smooth muscle cells, as evinced by intense staining of their nuclei with labeled oligonucleotides. Measurement of FITC-oligonucleotide in artery extracts showed significantly greater uptake in injured, compared with normal arteries. Light and electron microscopic studies demonstrated a correlation between the degree of damage and the amount of uptake. These results demonstrate that oligonucleotides penetrate easily into the arterial wall of balloon-injured arteries and accumulate in the medial smooth muscle cells-the target cells for antirestenosis therapeutics following balloon angioplasty.


Subject(s)
Aorta/metabolism , Muscle, Smooth, Vascular/metabolism , Oligonucleotides, Antisense/metabolism , Thionucleotides , Animals , Base Sequence , Biological Transport , Catheterization/adverse effects , Cells, Cultured , Dextrans , Female , Femoral Artery/metabolism , Femoral Artery/pathology , Fluorescein-5-isothiocyanate/analogs & derivatives , Fluorescent Dyes , Molecular Sequence Data , Muscle, Smooth, Vascular/pathology , Oligonucleotides, Antisense/chemical synthesis , Oligonucleotides, Antisense/pharmacokinetics , Rabbits
12.
Arch Surg ; 119(5): 615, 1984 May.
Article in English | MEDLINE | ID: mdl-6712478
14.
Fertil Steril ; 32(5): 613, 1979 Nov.
Article in English | MEDLINE | ID: mdl-499595
15.
AJR Am J Roentgenol ; 133(1): 162-3, 1979 Jul.
Article in English | MEDLINE | ID: mdl-110062
SELECTION OF CITATIONS
SEARCH DETAIL
...